Concepedia

Anita Kohli

AK

Statistics

Publications

51

Citations

6.7K

H-Index

31

Active since

2002

Affiliations

Gilead Sciences (United States)(Current)

National Institute of Allergy and Infectious Diseases

National Institutes of Health

University of Maryland, Baltimore

Arizona Liver Health

Anita Kohli is an author at Gilead Sciences (United States) specializing in medicine, hepatology, and viral hepatitis.

ORCID

Top concepts

Publications per year

2002–2023

51

Publications

51

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

David M. Weinreich, Sumathi Sivapalasingam, Thomas Norton et al. · New England Journal of Medicine · 2020 · 1.8K citations · Full text

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

, , +7

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

, , +9

Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH

Rohit Loomba, Mazen Noureddin, Kris V. Kowdley et al. · Hepatology · 2020 · 260 citations

Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials

Quentin M. Anstee, Eric Lawitz, Naim Alkhouri et al. · Hepatology · 2019 · 258 citations

Rows per page

1–5 of 51